갑상선 유두상 암종에 BRAF V600E 돌연변이 상태 차이점 분석
Analysis of Differential BRAFV600E Mutational Status in Papillary Thyroid Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
.
Abstract
Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, accounting for 95% or more of malignancies in Korea. Recently, many thyroid cancers have been detected owing to the widespread use of ultrasonography in health surveillance. The objective of this study was to evaluate the association of known prognostic factors with the BRAFV600E mutation and its association features in Korean patients with papillary thyroid carcinomas. The BRAFV600E mutation was detected in 69.1% (256 of 370) of PTC cases. In univariate analysis, the BRAFV600E mutation was significantly associated with tumor size (p < 0.05) and sex. However, it was not significantly associated with other established risk factors, such as age, extrathyroidal extension, and lymph node metastasis. This finding supports the idea that the BRAF mutation plays a role in the early stage of PTC development. This relationship deserves further investigation to clarify whether BRAFV600E is a useful risk factor or prognostic marker for PTC.
참고문헌 (18)
- Cahill S, "Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model", Mol Cancer, 6, pp.21~25 (2007)
- Davies H, "Mutations of the BRAF gene in human cancer", Nature, 417, pp.949~954 (2002)
- Donohue JH, "Do the prognosis of papillary and follicular thyroid cancer", Am J. Surg, 148, pp.168~173 (1984)
- Fugazzola L, "BRAF mutations in an Italian cohort of thyroid cancers", Clinical Endocrinology, 61, pp.239~243 (2004)
- Ito Y, "An observation trial without surgical treatment in patients with papillary micro carcinoma of the thyroid.", Thyroid Journal, 13, pp.381~387 (2003)
- 김경희, "Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population", Yonsei Medical Journal, 45(5), pp.818~821 (2004), 연세대학교의과대학
- 최윤라, "초미세 갑상샘 유두암종에서의 BRAF 돌연변이 검출", Journal of Pathology and Translational Medicine, 44(3), pp.308~314 (2010), 대한병리학회
- Knauf JA, "Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergode differentiation", Cancer Res, 65, pp.4238~4245 (2005)
- Kucuk NO, "Treatment for microcarcinoma of the thyroid: clinical experience", Clin Nucl Med, 32, pp.279~281 (2007)
- Kwak JY, "Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid carcinoma", Radiology, 253, pp.854~860 (2009)
- Park YJ, "Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E)mutation, clinico pathological features, and immunohistochemical findings", Head Neck, 32, pp.38~45 (2010)
- Puxeddu E, "BRAF(V599E)mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas", Journal of Clinical Endocrinology and Metabolism, 89, pp.2414~2420 (2004)
- Ruegemer JJ, "Distant metastases in differentiated thyroid carcinoma:a multivariate analysis of prognostic variables", J Clin Endocrinol Metab, 67, pp.501~508 (1988)
- Sakorafas GH, "Papillary tyroid microcarcinoma a surgical perspective", Cancer Treat Rev, 31, pp.423~438 (2005)
- Xing M, "BRAF mutation in thyroid cancer", Endocr Relat Cancer, 12, pp.245~262 (2005)
- Xu X, "High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines", Cancer Research, 63, pp.4561~4456 (2003)
- Annual report of cancer incidence(2007), cancer prevalence(2007) and survival(1993-2007) in Korea, "Ministry for Health, welfare and Family Affairs", Ministry for Health, welfare and Family Affairs, ~ (2007)